Inozyme Pharma Inc. (INZY) Social Stream
INOZYME PHARMA INC (INZY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INZY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $40 | $31 | $35.333 | $4.25 | 731.36% |
| 2021-11-29 | 5 | $40 | $23 | $32.25 | $4.25 | 658.82% |
| 2022-02-07 | 6 | $40 | $23 | $32.4 | $4.25 | 662.35% |
| 2022-03-16 | 6 | $40 | $23 | $30.4 | $4.25 | 615.29% |
| 2022-03-17 | 6 | $40 | $23 | $30 | $4.25 | 605.88% |
| 2022-04-14 | 6 | $40 | $23 | $29.4 | $4.25 | 591.76% |
| 2022-05-10 | 6 | $40 | $23 | $29 | $4.25 | 582.35% |
| 2022-05-11 | 6 | $40 | $20 | $26.4 | $4.25 | 521.18% |
| 2022-05-26 | 7 | $40 | $5 | $22.833 | $4.25 | 437.25% |
| 2022-05-27 | 7 | $40 | $5 | $20.666 | $4.25 | 386.26% |
| 2022-08-13 | 6 | $40 | $5 | $20.166 | $4.25 | 374.49% |
| 2022-08-15 | 7 | $40 | $5 | $20.166 | $4.25 | 374.49% |
| 2022-09-17 | 7 | $40 | $4.5 | $20.083 | $4.25 | 372.54% |
| 2022-11-11 | 7 | $40 | $4.5 | $18.1 | $4.25 | 325.88% |
| 2023-02-08 | 6 | $40 | $4.5 | $18.916 | $4.25 | 345.08% |
| 2023-02-17 | 7 | $40 | $4.5 | $18.916 | $4.25 | 345.08% |
| 2023-03-23 | 7 | $40 | $6 | $19.333 | $4.25 | 354.89% |
| 2023-04-19 | 7 | $40 | $6 | $19.166 | $4.25 | 350.96% |
| 2023-07-26 | 7 | $40 | $12 | $20.833 | $4.25 | 390.19% |
| 2023-08-02 | 7 | $40 | $13 | $21 | $4.25 | 394.12% |
| 2023-08-08 | 7 | $40 | $13 | $20.5 | $4.25 | 382.35% |
| 2023-09-12 | 7 | $40 | $12 | $20.333 | $4.25 | 378.42% |
| 2023-11-13 | 7 | $40 | $15 | $21 | $4.25 | 394.12% |
The Trend in the Analyst Price Target
Over the past 18 months, INZY's average price target has gone down $5.4.
INZY reports an average of 434.73% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 7 | 40 | 4.5 | 18.916 | 2.10 | 800.76% |
| 2023-02-17 | 7 | 40 | 4.5 | 18.916 | 2.89 | 554.53% |
| 2023-03-27 | 7 | 40 | 6.0 | 19.166 | 3.70 | 418% |
| 2023-05-16 | 7 | 40 | 11.0 | 20.833 | 6.65 | 213.28% |
| 2023-08-14 | 7 | 40 | 12.0 | 20.333 | 4.95 | 310.77% |
INZY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 6 | 1 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 18 months, INZY's average broker recommendation rating improved by 0.03.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INZY as an investment opportunity.
- In the context of all US stocks, INOZYME PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 2422.43% of them.
- INOZYME PHARMA INC's variance in analysts' estimates is lower than -2138.68% of all US stocks.
- In terms of how INOZYME PHARMA INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 1954.52% of that group.
- INOZYME PHARMA INC's average analyst price target is greater than 1007.67% of Healthcare stocks.
In the Pharmaceutical Products industry, DYN, CMPS, and BIVI are the three stocks most similar to INOZYME PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for INZY? Use POWR Ratings for clearer insight into price direction.